Non-coding RNAs as regulators of the Hippo pathway in cardiac development and cardiovascular disease

Area of Science:

• Molecular Biology
• Cardiovascular Science
• Genetics

Background:

• Cardiovascular diseases (CVDs) result from complex gene-environment interactions affecting multiple signaling pathways.
• The Hippo pathway is a conserved regulator of cell proliferation, apoptosis, and differentiation, implicated in CVDs, cancer, and regeneration.
• Non-coding RNAs (ncRNAs) are key gene expression regulators with diverse functions, increasingly recognized in disease mechanisms.

Purpose of the Study:

• To review the regulatory roles of ncRNAs in the Hippo pathway concerning cardiovascular diseases.
• To explore the therapeutic potential of targeting ncRNA-Hippo pathway interactions for CVD treatment and prevention.

Main Methods:

• Literature review of recent studies on ncRNAs, the Hippo pathway, and cardiovascular diseases.
• Analysis of molecular mechanisms underlying ncRNA regulation of Hippo pathway components.
• Identification of potential therapeutic targets within these interactions.

Main Results:

• ncRNAs modulate Hippo pathway activity, influencing myocardial fibrosis, cardiomyocyte proliferation, apoptosis, and hypertrophy.
• Specific ncRNAs and Hippo pathway components are identified as critical players in cardiovascular disease pathogenesis.
• The interplay between ncRNAs and the Hippo pathway presents novel avenues for therapeutic intervention.

Conclusions:

• ncRNA-Hippo pathway interactions are crucial in cardiovascular disease development.
• Targeting these interactions holds promise for developing new therapeutic strategies for cardiovascular diseases.
• Further research into these molecular mechanisms can uncover innovative treatments and preventive measures for CVDs.